MMP9 and breast carcinoma: Among MMP-9 polymorphisms, 1562 C/T (rs 3918242), a C to T substitution at −1562 bp, is the most studied.14 Researches have been performed to confirm the relationship between the pointed polymorphism and breast cancer susceptibility, however results are inconclusive.14